Studies related to pancreatic cancer biomarkers are more complementary; glypican-1 (GPC1), MIF, EGFR are all used to successfully diagnose patients with healthy controls (Li et al., 2018). The gene discussed is GPC1; the disease is familial pancreatic carcinoma.